These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33463624)

  • 1. Comments on: Monocyte to high-density lipoprotein ratio in central serous chorioretinopathy: A biomarker of inflammation or epiphenomenon.
    Jain M; Gerges F
    Indian J Ophthalmol; 2021 Feb; 69(2):471. PubMed ID: 33463624
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to comments on: Monocyte to high-density lipoprotein and neutrophil-to-lymphocyte ratios in patients with acute central serous chorioretinopathy.
    Sirakaya E; Duru Z; Kuçuk B; Duru N
    Indian J Ophthalmol; 2021 Feb; 69(2):472. PubMed ID: 33463625
    [No Abstract]   [Full Text] [Related]  

  • 3. Monocyte to high-density lipoprotein and neutrophil-to-lymphocyte ratios in patients with acute central serous chorioretinopathy.
    Sirakaya E; Duru Z; Kuçuk B; Duru N
    Indian J Ophthalmol; 2020 May; 68(5):854-858. PubMed ID: 32317461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: Our understanding of central serous chorioretinopathy-coming a full circle?
    Mohan A; Soman M; Nair RU
    Indian J Ophthalmol; 2020 May; 68(5):858-859. PubMed ID: 32317462
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: Systemic immune-inflammatory indices and their association with ocular disorders-Do we have economical and reliable biomarkers?
    Madanagopalan VG
    Indian J Ophthalmol; 2020 May; 68(5):859-860. PubMed ID: 32317463
    [No Abstract]   [Full Text] [Related]  

  • 6. Smokestack leak on indocyanine green angiography in acute central serous chorioretinopathy.
    Ayachit A; Kumar V; Raj N; Ayachit G
    Indian J Ophthalmol; 2018 Aug; 66(8):1181-1182. PubMed ID: 30038170
    [No Abstract]   [Full Text] [Related]  

  • 7. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography.
    De Bats F; Cornut PL; Wolff B; Kodjikian L; Mauget-Faÿsse M
    Eur J Ophthalmol; 2018 Jul; 28(4):446-453. PubMed ID: 29554817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bilateral abnormalities in central serous chorioretinopathy seen in optical coherence tomography, ultra-widefield fluorescein angiography and microperimetry--case report].
    Tylus M; Święch-Zubilewicz A; Dolar-Szczasny J; Mackiewicz J
    Klin Oczna; 2015; 117(3):173-6. PubMed ID: 26999941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
    Koytak A; Erol K; Coskun E; Asik N; Öztürk H; Özertürk Y
    Retina; 2010; 30(10):1698-703. PubMed ID: 20539254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central serous chorioretinopathy with typical "smokestack"].
    Rabi Andaloussi Z; Affortit A
    J Fr Ophtalmol; 2015 May; 38(5):463-5. PubMed ID: 25890590
    [No Abstract]   [Full Text] [Related]  

  • 11. Central serous chorioretinopathy after surgical repair of a blowout fracture.
    Chang M; Baek S; Lee TS
    J Craniofac Surg; 2012 Nov; 23(6):1923-4. PubMed ID: 23172445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central serous chorioretinopathy mimicking as choroiditis.
    Panigrahi PK; Mahapatra MM; Minj A; Satapathy J; Samant S
    Clin Exp Optom; 2018 May; 101(3):420-421. PubMed ID: 29134698
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of central serous chorioretinopathy: Expert panel discussion.
    Chhablani J; Anantharaman G; Behar-Cohen F; Boon C; Manayath G; Singh R
    Indian J Ophthalmol; 2018 Dec; 66(12):1700-1703. PubMed ID: 30451169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual peripapillary new vessels in eye with central serous chorioretinopathy.
    Roy R; Saurabh K; Bhende MP; Das D; Jain AB
    Clin Exp Optom; 2015 Nov; 98(6):574-6. PubMed ID: 25944144
    [No Abstract]   [Full Text] [Related]  

  • 15. Central serous chorioretinopathy: a personal perspective.
    Yannuzzi LA
    Am J Ophthalmol; 2010 Mar; 149(3):361-363. PubMed ID: 20172062
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticosteroids usage and central serous chorioretinopathy: a meta-analysis.
    Ge G; Zhang Y; Zhang Y; Xu Z; Zhang M
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):71-77. PubMed ID: 31734720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Bousquet E; Bonnin S; Mrejen S; Krivosic V; Tadayoni R; Gaudric A
    Retina; 2018 Mar; 38(3):629-638. PubMed ID: 28267114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of three-dimensional optical coherence tomography and fundus photochromy in correlating the fluorescein leaking sites of acute central serous chorioretinopathy.
    Wang GH; Zhang J; Zhang D; Lv FL; Wang LX
    Med Princ Pract; 2011; 20(3):283-6. PubMed ID: 21455001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masqueraders of central serous chorioretinopathy.
    Sahoo NK; Singh SR; Rajendran A; Shukla D; Chhablani J
    Surv Ophthalmol; 2019; 64(1):30-44. PubMed ID: 30243734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of chronic central serous chorioretinopathy.
    Hanumunthadu D; Tan ACS; Singh SR; Sahu NK; Chhablani J
    Indian J Ophthalmol; 2018 Dec; 66(12):1704-1714. PubMed ID: 30451170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.